Indicated for the management of the signs of mild, moderate or severe (modified NYHA Class IIa,IIb, IVc) congestive heart failure
in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM). Use with concurrent therapy for
congestive heart failure (i.e. furosemide, etc) on a case by case basis. 2.5mg Chewable Tablets. 50/Bottle.
in dogs due to atrioventricular valvular insufficiency (AVVI) or dilated cardiomyopathy (DCM). Use with concurrent therapy for
congestive heart failure (i.e. furosemide, etc) on a case by case basis. 2.5mg Chewable Tablets. 50/Bottle.